will be African by 2050
Home to the youngest, fastest-growing population on Earth.
Precision Health. African Scale.
A quality-verified precision health platform
Built for African scale.
Beginning with research-grade supply held to documentation-led standards. We're in R&D, ahead of a planned September 2026 launch.
Current Phase: R&D
Planned Launch: September 2026
Built Around: Verification + Documentation
Our Mission
Better health, within reach.
Africa is the youngest, fastest-growing continent on Earth — and its health needs are rising just as fast.
Too often, the care within reach is the wrong answer: counterfeit medicine, overstretched clinics, and private treatment most families simply cannot afford. Every year, millions are forced to seek care abroad — draining household savings and entire economies.
Pevaris Labs exists to change that — bringing a new standard of precision health home: quality-verified, transparently documented, and at a fraction of today's cost.
Chronic & non-communicable burden
Rising
PastNowComing years
Illustrative of widely reported public-health trends in Africa — not Pevaris Labs data, and not a medical or product claim.
The challenge
the rising cause of death
Chronic conditions are projected to become Africa's leading killer by 2030.
medicines are fake or substandard
In lower-income countries, people pay for medicine that may not work (WHO).
lost to care sought abroad
Costly private care drains family savings and local economies every year.
Figures reflect widely reported UN and WHO projections — illustrative context, not Pevaris Labs data or a medical claim.
The Pevaris Mission
How we verify quality →
To bring Africa a new standard of precision health — cost-effective, locally delivered, and transparently documented — at a fraction of today's cost.
Research-use positioning only. Pevaris Labs is not currently offering products for sale through this website.
Verification & Sourcing
Built on verification,
Built on verification,
not assumptions.
The trust around the product is the product — sourced from vetted suppliers, tested by independent European laboratories, and documented at every step of the supply chain.
STEP 01
Source
Vetted, qualified suppliers
STEP 02
Verify
Independent European lab testing
STEP 03
Document
Evidence recorded & traceable
STEP 04
Release
Only after the gate clears
Disciplined sourcing
Every supplier is independently vetted and qualified before a single compound is sourced. Quality starts at the origin.
Independent European lab testing
Every batch is tested by independent European laboratories to a ≥99% purity standard. No verification, no release.
Transparent documentation
Full, traceable documentation follows every compound across the entire supply chain — proof, not promises.
Our Model
The model we're building.
A modern, transparent precision-health company — built on one verified source and reaching the market four ways: owned clinic-stores across Africa, our Aevia direct-to-consumer brand online, white-label wholesale to brands, and research-grade API peptides supplied to the US and EU. This is the model Pevaris Labs is building toward.
01 — The Clinic
A modern clinic, built around you.
Step into a Pevaris space and meet a qualified team. Through specialist consultation and assessment, the aim is a precision-health plan shaped around the individual — with ongoing reviews and adjustments over time. A calm, professional environment, designed for trust.
02 — The Product
Quality you can verify.
Every compound is sourced with discipline, tested by independent European laboratories, and backed by transparent documentation — so quality is something you can see, not simply trust. Explore the research portfolio we are building.
View the Peptides Catalog →
03 — The Experience
Designed for ease and confidence.
From clinic to home, everything arrives in a clean, ready-to-use kit — vial, sterile single-use syringes, and a reusable pen — thoughtfully packaged to make the experience simple, safe, and reassuring.
PEVAapp preview coming
04 — The Peva App
Your plan, in your pocket.
The Peva app keeps every plan on track: daily doses and reminders, automatic dose-step scheduling, and reorder alerts before you run low. Track your progress and milestones, get the right guidance at the right moment, and message the Pevaris team directly — all built to work on everyday phones, online or off.
E-Commerce — US & EU
A brand of our own: Aevia.
Pevaris is building a dedicated direct-to-consumer daughter brand — Aevia — an online store bringing the same verified, independently tested compounds straight to people. Two dedicated storefronts — one for the EU, and one for the US.
EU storefront
US storefront
Launching 2026
Routes to market
One verified source, four ways to reach the market.
Owned clinic-stores
A network of Pevaris precision-health stores across Africa — eight locations built and operated over a 24-month rollout.
Wholesale, non-branded
Bulk non-branded vials — with the option to carry your own brand — supplied to established brands across the US and EU.
E-Commerce
A dedicated Pevaris daughter brand, Aevia, bringing verified compounds to people online — one EU store, one US store.
API peptides
The highest-grade active peptide — independently EU + US verified — marketed and supplied to research customers across the US and EU.
Your brand here →
Wholesale — US & EU
Your brand. Our quality.
We supply bulk, non-branded vials to established brands — with the option to label them as your own. The same disciplined sourcing and independent European laboratory testing behind every Pevaris vial, available as the quiet engine behind your product line. The highest quality in the market — under your name, or ours.
≥99%HPLC PURITY STANDARD
EUINDEPENDENT LAB TESTED
100%DOCUMENTED & TRACEABLE
At volume
Supplied at scale — non-branded or white-labelled.
From pilot runs to recurring volume, brands across the US and EU can build on Pevaris-grade vials — non-branded, white-labelled, or co-developed — every batch independently European-lab tested.
API Peptides — US & EU
Explore our API approach →
The active peptide, verified and taken to market.
Beyond finished vials, Pevaris supplies the highest-grade active peptide (API) in bulk — secured from verified manufacturers, put through the same independent European and US laboratory testing, and marketed to research customers across the US and EU. We bring the verification and, with deep US-market expertise, the customers. The product is the proof.
≥99%HPLC PURITY STANDARD
EU + USINDEPENDENTLY TESTED
g → kgBULK QUANTITIES
Forward-looking — the clinics, the Aevia direct-to-consumer brand, the white-label wholesale supply, and the research-grade API supply together describe the model Pevaris Labs is building toward. Research-use positioning only, presented for general information; Pevaris Labs is not currently offering products or services for sale through this website.
Current Stage
Research & Development.
We are not selling products, and we are not rushing to market. We are building the foundations carefully — so that what follows can be trusted.
Market research
Supplier verification prep
Quality framework design
Documentation systems
Compliance review
Market entry planning
Partner conversations
Launch readiness
Detailed product, supplier, and technical information will be released closer to launch after
verification work is complete.
Pevaris Labs is not currently offering products for sale through this website.
Roadmap
Planned launch timeline
Now
Research & Development
Next
Supplier Verification
After Verification
Launch Preparation
September 2026
Aevia E-Commerce
November 2026
First Clinic · Nairobi
Post-Launch
Scale Phase
No verification. No release.
The Vision
Where Pevaris Labs is going.
A long-term build. We establish the trust layer first — verified supply and documentation — then expand, deliberately, toward a broader precision-health platform.
Building the foundation
Verification systems, documentation standards, and a quality framework — supported by trusted, globally-sourced research supply held to a single standard.
A multi-market supply platform
A quality-verified research-supply platform operating across multiple markets — documentation-backed, supplier-resilient, and trusted by a growing network of partners and institutions.
A precision-health platform
An expansion toward broader precision and digital health — research formulations developed for the priorities of our markets, a consumer-facing digital layer, and one of the region's most significant real-world precision-health data foundations.
Forward-looking direction shown for context. Illustrative, not a guarantee; all future activity is subject to verification, documentation, and market-specific legal review.
Partnership
Building this requires
Building this requires
the right partners.
We are opening early, selective conversations with aligned collaborators who share a long-term, quality-first view of African precision health.
Partner With Pevaris Labs →Thank you — message received.
We've noted your interest. As a verification-led company, we respond selectively and in confidence. Deeper materials will be shared closer to launch.